Status:
UNKNOWN
Thyroid Dysfunction in Patients With Nephrotic Syndrome
Lead Sponsor:
Merna Makram
Collaborating Sponsors:
Assiut University
Conditions:
Thyroid Dysfunction
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
This study is to evaluate Thyroid Hormone profile in patients with Nephrotic syndrome to identify clinical predictor of Thyroid dysfunction in patients with Nephrotic syndrome
Detailed Description
Nephrotic syndrome (NS) is one of the most popular glomerular diseases all over the world It result in loss of various macromolecules which exist in the plasma and bound to plasma proteins. They are c...
Eligibility Criteria
Inclusion
- Nephrotic syndrome defined by the following:
- Generalized edema
- Urine protein excretion \> 3,5 g/24 hours
- Urine protein to creatinine ratio \> 3,500mg/g
- Serum albumin level less than 30 g/L
Exclusion
- \- 1) Patients \< 18 years old 2) Patients who have Thyroid diseases, current or past history of thyroid hormone or antithyroid drug intake.
- 3\) Patients who have diabetes mellitus or autoimmune diseases as systemic lupus erythematosus and RA 4) Medications known to affect thyroid function. 5) Patients with liver cirrhosis and chronic liver disease as augmentin
Key Trial Info
Start Date :
October 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2022
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04323007
Start Date
October 1 2020
End Date
October 1 2022
Last Update
March 26 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.